Vaginal rings delivering progesterone and estradiol may be a new method of hormone replacement therapy (HTML)
Maruo,Takeshi; Mishell,Daniel R.,Jr.; Ben-Chetrit,Avraham; Hochner-Celnikier,Drorith; Hamada,Anna Lissa; Nash,Harold A.
Fertility and Sterility 78(5): 1010-1016
Publication date: 2002
To determine whether a low dose of P delivered together with E2 from a vaginal ring on a continuous schedule can prevent endometrial proliferation and yield a bleeding pattern dominated by amenorrhea.
Longitudinal clinical study.
Three university hospitals.
Fifty-five women 45 to 75 years of age, not hysterectomized, with E2 levels of <20 pg/mL and hot-flash incidence of two or more per day in the past week.
A vaginal ring delivering approximately 150 µg/d of 17ß-E2 and approximately 5 mg/d or approximately 9 mg/d of P used continuously for 4 and 6 months.
Main Outcome Measure(s)
Endometrial thickness, bleeding pattern, and hot flash incidence.
Endometrial proliferation was prevented by both P doses. Bleeding incidence decreased. In months 4, 5, and 6, 8 of 12 women had no bleeding. Incidence of hot flashes and night sweats decreased quickly and significantly.
A vaginal ring delivering E2 and a low dose of P merits further study as a method for long-term hormone replacement therapy.
For 60 years, the Population Council has changed the way the world thinks about important health and development issues. Explore an interactive timeline of the Council's history, learn more about some of our key contributions, and watch a short video about why your support is so important to us.